Keywords: vioxx, different, cox-2s, study, new, published, atherosclerosis

Vioxx different to other COX-2s; study

Article | 22 November 2004

Print This

A new study published in Atherosclerosis suggests that there are important differences between Merck & Co's Vioxx (rofecoxib) and other COX-2 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in